Logo image of VALUE.AS

VALUE8 NV (VALUE.AS) Stock Fundamental Analysis

AMS:VALUE - Euronext Amsterdam - NL0010661864 - Common Stock - Currency: EUR

5.8  -0.18 (-2.99%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to VALUE. VALUE was compared to 106 industry peers in the Capital Markets industry. VALUE gets an excellent profitability rating and is at the same time showing great financial health properties. VALUE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year VALUE was profitable.
In the past year VALUE had a positive cash flow from operations.
Of the past 5 years VALUE 4 years were profitable.
Of the past 5 years VALUE 4 years had a positive operating cash flow.
VALUE.AS Yearly Net Income VS EBIT VS OCF VS FCFVALUE.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

With an excellent Return On Assets value of 11.02%, VALUE belongs to the best of the industry, outperforming 90.57% of the companies in the same industry.
With a decent Return On Equity value of 11.91%, VALUE is doing good in the industry, outperforming 67.92% of the companies in the same industry.
VALUE's Return On Invested Capital of 9.21% is amongst the best of the industry. VALUE outperforms 84.91% of its industry peers.
Industry RankSector Rank
ROA 11.02%
ROE 11.91%
ROIC 9.21%
ROA(3y)6.39%
ROA(5y)8.26%
ROE(3y)7.47%
ROE(5y)9.12%
ROIC(3y)N/A
ROIC(5y)N/A
VALUE.AS Yearly ROA, ROE, ROICVALUE.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

VALUE has a better Profit Margin (84.12%) than 94.34% of its industry peers.
VALUE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 88.66%, VALUE belongs to the top of the industry, outperforming 96.23% of the companies in the same industry.
In the last couple of years the Operating Margin of VALUE has grown nicely.
VALUE has a better Gross Margin (92.72%) than 88.68% of its industry peers.
In the last couple of years the Gross Margin of VALUE has remained more or less at the same level.
Industry RankSector Rank
OM 88.66%
PM (TTM) 84.12%
GM 92.72%
OM growth 3Y1.03%
OM growth 5Y2.21%
PM growth 3Y-0.98%
PM growth 5Y2.05%
GM growth 3Y-0.93%
GM growth 5Y0.58%
VALUE.AS Yearly Profit, Operating, Gross MarginsVALUE.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

More info and screens

8

2. Health

2.1 Basic Checks

VALUE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for VALUE has been reduced compared to 5 years ago.
VALUE has a worse debt/assets ratio than last year.
VALUE.AS Yearly Shares OutstandingVALUE.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
VALUE.AS Yearly Total Debt VS Total AssetsVALUE.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

VALUE has an Altman-Z score of 5.32. This indicates that VALUE is financially healthy and has little risk of bankruptcy at the moment.
VALUE's Altman-Z score of 5.32 is amongst the best of the industry. VALUE outperforms 91.51% of its industry peers.
VALUE has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as VALUE would need 2.91 years to pay back of all of its debts.
The Debt to FCF ratio of VALUE (2.91) is better than 83.02% of its industry peers.
VALUE has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.02, VALUE belongs to the best of the industry, outperforming 86.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.91
Altman-Z 5.32
ROIC/WACCN/A
WACCN/A
VALUE.AS Yearly LT Debt VS Equity VS FCFVALUE.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

VALUE has a Current Ratio of 3.87. This indicates that VALUE is financially healthy and has no problem in meeting its short term obligations.
VALUE's Current ratio of 3.87 is amongst the best of the industry. VALUE outperforms 85.85% of its industry peers.
VALUE has a Quick Ratio of 3.87. This indicates that VALUE is financially healthy and has no problem in meeting its short term obligations.
VALUE has a Quick ratio of 3.87. This is amongst the best in the industry. VALUE outperforms 85.85% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.87
VALUE.AS Yearly Current Assets VS Current LiabilitesVALUE.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 663.79% over the past year.
The Earnings Per Share has been growing slightly by 6.27% on average over the past years.
The Revenue has grown by 334.90% in the past year. This is a very strong growth!
VALUE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.02% yearly.
EPS 1Y (TTM)663.79%
EPS 3Y-25.19%
EPS 5Y6.27%
EPS Q2Q%355%
Revenue 1Y (TTM)334.9%
Revenue growth 3Y-23.23%
Revenue growth 5Y4.02%
Sales Q2Q%229.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VALUE.AS Yearly Revenue VS EstimatesVALUE.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.53, the valuation of VALUE can be described as very cheap.
Based on the Price/Earnings ratio, VALUE is valued cheaper than 96.23% of the companies in the same industry.
VALUE is valuated cheaply when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.53
Fwd PE N/A
VALUE.AS Price Earnings VS Forward Price EarningsVALUE.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, VALUE is valued a bit cheaper than 79.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.47
EV/EBITDA -0.32
VALUE.AS Per share dataVALUE.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

VALUE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.72
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

VALUE has a Yearly Dividend Yield of 3.09%.
VALUE's Dividend Yield is a higher than the industry average which is at 6.56.
VALUE's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
VALUE.AS Yearly Dividends per shareVALUE.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

4.32% of the earnings are spent on dividend by VALUE. This is a low number and sustainable payout ratio.
DP4.32%
EPS Next 2YN/A
EPS Next 3YN/A
VALUE.AS Yearly Income VS Free CF VS DividendVALUE.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M
VALUE.AS Dividend Payout.VALUE.AS Dividend Payout, showing the Payout Ratio.VALUE.AS Dividend Payout.PayoutRetained Earnings

More info and screens

VALUE8 NV

AMS:VALUE (5/9/2025, 7:00:00 PM)

5.8

-0.18 (-2.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners68.1%
Ins Owner ChangeN/A
Market Cap53.94M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP4.32%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.53
Fwd PE N/A
P/S 3.6
P/FCF 22.47
P/OCF 22.47
P/B 0.51
P/tB 0.51
EV/EBITDA -0.32
EPS(TTM)1.28
EY22.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.26
FCFY4.45%
OCF(TTM)0.26
OCFY4.45%
SpS1.61
BVpS11.4
TBVpS11.4
PEG (NY)N/A
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA 11.02%
ROE 11.91%
ROCE 12.54%
ROIC 9.21%
ROICexc 13.18%
ROICexgc 13.18%
OM 88.66%
PM (TTM) 84.12%
GM 92.72%
FCFM 16%
ROA(3y)6.39%
ROA(5y)8.26%
ROE(3y)7.47%
ROE(5y)9.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-32.03%
ROICexcg growth 5Y3.89%
ROICexc growth 3Y-32.03%
ROICexc growth 5Y3.92%
OM growth 3Y1.03%
OM growth 5Y2.21%
PM growth 3Y-0.98%
PM growth 5Y2.05%
GM growth 3Y-0.93%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.91
Debt/EBITDA 0.18
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 20.53
Cash Conversion 17.88%
Profit Quality 19.01%
Current Ratio 3.87
Quick Ratio 3.87
Altman-Z 5.32
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)663.79%
EPS 3Y-25.19%
EPS 5Y6.27%
EPS Q2Q%355%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)334.9%
Revenue growth 3Y-23.23%
Revenue growth 5Y4.02%
Sales Q2Q%229.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y777.44%
EBIT growth 3Y-22.44%
EBIT growth 5Y6.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y777.97%
FCF growth 3YN/A
FCF growth 5Y-55.57%
OCF growth 1Y777.97%
OCF growth 3YN/A
OCF growth 5Y-55.57%